Septerna, Inc. Common Stock (SEPN)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 130
- Market Cap
- $1.6B
About Septerna, Inc. Common Stock
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
SentiSense also tracks daily options readings for Septerna, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Septerna, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.